UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

RIN3 is a negative regulator of mast cell responses to SCF

PloS one, 2012-11, Vol.7 (11), p.e49615-e49615

2012

Volltextzugriff (PDF)

RIN1 orchestrates the activation of RAB5 GTPases and ABL tyrosine kinases to determine the fate of EGFR

Journal of cell science, 2012-12, Vol.125 (Pt 23), p.5887-5896

2012

Volltextzugriff (PDF)

Replication Stress and Telomere Dysfunction Are Present in Cultured Human Embryonic Stem Cells

Cytogenetic and genome research, 2015-01, Vol.146 (4), p.251-260

2015

Volltextzugriff (PDF)

Abstract A107: Inhibition of CCR2 potentiates the checkpoint inhibitor immunotherapy in pancreatic cancer

Cancer immunology research, 2016-11, Vol.4 (11_Supplement), p.A107-A107

2016

Volltextzugriff (PDF)

Abstract 564: Combination therapy of chemokine receptor inhibition plus PD-L1 blockade potentiates antitumor effects in a murine model of breast cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.564-564

2016

Volltextzugriff (PDF)

Abstract 5655: Inhibition of CCR2 potentiates checkpoint inhibitor immunotherapy in murine model of pancreatic cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5655-5655

2017

Volltextzugriff (PDF)

Abstract 1745: Inhibition of chemokine receptor 2 (CCR2) with a small molecule antagonist enhances the effectiveness of checkpoint inhibition by altering the tumor microenvironment in mouse colorectal tumors: Reducing tumor size and increasing long term survival

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1745-1745

2018

Volltextzugriff (PDF)

RIN3 negatively regulates SCF-mediated responses of mast cells

Janson, Christine Marie

2012

Volltextzugriff (PDF)

RIN Family Proteins (RIN1, RIN2, and RIN3)

Encyclopedia of Signaling Molecules, p.4740-4744

Volltextzugriff (PDF)

Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization

Proceedings of the National Academy of Sciences - PNAS, 2012-07, Vol.109 (29), p.11788-11793

2012

Volltextzugriff (PDF)

Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level

Bone marrow transplantation (Basingstoke), 2020-12, Vol.55 (12), p.2286-2293

2020

Volltextzugriff (PDF)

Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor T cell therapy

Haematologica (Roma), 2023-02, Vol.108 (2), p.444

2023

Volltextzugriff (PDF)

Correction: Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level

Bone marrow transplantation (Basingstoke), 2021-10, Vol.56 (10), p.2617-2617

2021

Volltextzugriff (PDF)

Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML

Bone marrow transplantation (Basingstoke), 2021-11, Vol.56 (11), p.2834-2841

2021

Volltextzugriff (PDF)

Loss of ventricular preexcitation during noninvasive testing does not exclude high-risk accessory pathways: A multicenter study of WPW in children

Heart rhythm, 2020-10, Vol.17 (10), p.1729-1737

2020

Volltextzugriff (PDF)

Indoor Airborne Microbiome and Endotoxin: Meteorological Events and Occupant Characteristics Are Important Determinants

Environmental science & technology, 2023-08, Vol.57 (32), p.11750-11766

2023

Volltextzugriff (PDF)

Advancing the science of symptom management

Journal of advanced nursing, 2001-03, Vol.33 (5), p.668-676

2001

Volltextzugriff (PDF)

Allogeneic hematopoetic stem cell transplant for patients with refractory T‐Cell lymphomas

European journal of haematology, 2024-02, Vol.112 (2), p.276-285

2024

Volltextzugriff (PDF)

Development and Validation of a Concise Objectifiable Risk Evaluation Score for Non-Relapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation

Cancers, 2024-01, Vol.16 (3), p.515

2024

Volltextzugriff (PDF)

Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation

HemaSphere, 2023-07, Vol.7 (7), p.e921-n/a

2023

Volltextzugriff (PDF)

Post-Transplant MRD Negativity on Day +100 Predicts Outcomes for Pre-Transplant Relapsed/Refractory AML Patients

Blood, 2021-11, Vol.138 (Supplement 1), p.4909-4909

2021

Volltextzugriff (PDF)

Treosulfan-Based Conditioning Regimen for Second Allograft in Patients with Myelofibrosis

Cancers, 2020-11, Vol.12 (11), p.3098

2020

Volltextzugriff (PDF)

Spleen volume and length determined by computed tomography impact outcome after allogeneic stem cell transplantation for myelofibrosis

Bone marrow transplantation (Basingstoke), 2023-07, Vol.58 (7), p.755-761

2023

Volltextzugriff (PDF)

Association of perinatal characteristics with biomarkers of stress and inflammation in young adults: An exploratory study

Comprehensive Psychoneuroendocrinology (Online), 2024-08, Vol.19, p.100249, Article 100249

2024

Volltextzugriff (PDF)

Viral Reactivation and Immune Reconstitution after CAR-T Cell Treatment in Patients with Hematologic Malignancies

Blood, 2022-11, Vol.140 (Supplement 1), p.7531-7532

2022

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

Englisch
(80)
Japanisch
(10)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

RIN3 is a negative regulator of mast cell responses to SCF

RIN1 orchestrates the activation of RAB5 GTPases and ABL tyrosine kinases to determine the fate of EGFR

Replication Stress and Telomere Dysfunction Are Present in Cultured Human Embryonic Stem Cells

Abstract A107: Inhibition of CCR2 potentiates the checkpoint inhibitor immunotherapy in pancreatic cancer

Abstract 564: Combination therapy of chemokine receptor inhibition plus PD-L1 blockade potentiates antitumor effects in a murine model of breast cancer

Abstract 5655: Inhibition of CCR2 potentiates checkpoint inhibitor immunotherapy in murine model of pancreatic cancer

Abstract 1745: Inhibition of chemokine receptor 2 (CCR2) with a small molecule antagonist enhances the effectiveness of checkpoint inhibition by altering the tumor microenvironment in mouse colorectal tumors: Reducing tumor size and increasing long term survival

RIN3 negatively regulates SCF-mediated responses of mast cells

RIN Family Proteins (RIN1, RIN2, and RIN3)

Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization

Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level

Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor T cell therapy

Correction: Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level

Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML

Loss of ventricular preexcitation during noninvasive testing does not exclude high-risk accessory pathways: A multicenter study of WPW in children

Indoor Airborne Microbiome and Endotoxin: Meteorological Events and Occupant Characteristics Are Important Determinants

Advancing the science of symptom management

Allogeneic hematopoetic stem cell transplant for patients with refractory T‐Cell lymphomas

Development and Validation of a Concise Objectifiable Risk Evaluation Score for Non-Relapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation

Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation

Post-Transplant MRD Negativity on Day +100 Predicts Outcomes for Pre-Transplant Relapsed/Refractory AML Patients

Treosulfan-Based Conditioning Regimen for Second Allograft in Patients with Myelofibrosis

Spleen volume and length determined by computed tomography impact outcome after allogeneic stem cell transplantation for myelofibrosis

Association of perinatal characteristics with biomarkers of stress and inflammation in young adults: An exploratory study

Viral Reactivation and Immune Reconstitution after CAR-T Cell Treatment in Patients with Hematologic Malignancies

Suchergebnisse filtern